tradingkey.logo

Hinge Health Inc

HNGE
查看詳細走勢圖
47.920USD
-1.490-3.02%
收盤 01/09, 16:00美東報價延遲15分鐘
3.77B總市值
虧損本益比TTM

Hinge Health Inc

47.920
-1.490-3.02%
盤中分時
1分
30分
1小時
日k
週k
月k
日k

今天

-3.02%

5天

+5.18%

1月

-3.56%

6月

+8.56%

今年開始到現在

+3.16%

1年

0.00%

查看詳細走勢圖

TradingKey Hinge Health Inc股票評分

單位: USD 更新時間: 2026-01-09

操作建議

Hinge Health Inc當前公司基本面數據相對非常健康,增長潛力很大。當前估值合理,在醫療服務供應商行業排名27/77位。機構持股佔比非常高,近一月多位分析師給出公司評級為買入。最高目標價為63.93。中期看,股價處於平穩狀態。近一個月,市場表現一般,但公司基本面和技術面得分較高。目前股價在壓力位和支撐位之間,可以做區間波段操作。

Hinge Health Inc評分

相關信息

行業排名
27 / 77
全市場排名
140 / 4562
所屬行業
醫療服務供應商

壓力支撐

由於公司未披露,未能獲取相關數據

多維評測

本期評分
上期評分

公司輿情

過去24小時
熱度

過冷
過熱
看空

Hinge Health Inc亮點

亮點風險
Hinge Health, Inc. leverages software, including artificial intelligence (AI), to largely automate care for joint and muscle health. The Company has designed its TrueMotion platform to address a spectrum of musculoskeletal (MSK) care from acute injury to chronic pain, to post-surgical rehabilitation. Members receive personalized and automated MSK care through its AI-powered motion tracking technology. It offers electrical nerve stimulation wearable device Enso, all designed and monitored by its AI-supported care team of licensed physical therapists, physicians, and board-certified health coaches. Its platform offers a range of support with multiple programs across many affected areas to provide a continuum of care from prevention to treatment of acute injury and chronic pain, as well as surgery decision support and post-surgical recovery. Enso delivers electrical nerve stimulation designed to provide non-addictive and non-invasive pain relief.
估值低估
公司最新PE估值-5.03,處於3年歷史低位
機構加倉
最新機構持股39.98M股,環比增加10.38%
喬治·索羅斯持倉
明星投資者喬治·索羅斯持倉,最新持倉78.56K股

分析師目標

基於 15 分析師
買入
評級
63.929
目標均價
+36.37%
漲幅空間
數據免責聲明:分析師評級與目標價由LSEG提供,僅供參考,不應當作投資建議

Hinge Health Inc新聞

即將為您帶來更多新聞,敬請期待。 。 。

財務指標

每股收益

由於公司未披露,未能獲取相關數據

營業總收入

由於公司未披露,未能獲取相關數據

Hinge Health Inc簡介

Hinge Health, Inc. leverages software, including artificial intelligence (AI), to largely automate care for joint and muscle health. The Company has designed its TrueMotion platform to address a spectrum of musculoskeletal (MSK) care from acute injury to chronic pain, to post-surgical rehabilitation. Members receive personalized and automated MSK care through its AI-powered motion tracking technology. It offers electrical nerve stimulation wearable device Enso, all designed and monitored by its AI-supported care team of licensed physical therapists, physicians, and board-certified health coaches. Its platform offers a range of support with multiple programs across many affected areas to provide a continuum of care from prevention to treatment of acute injury and chronic pain, as well as surgery decision support and post-surgical recovery. Enso delivers electrical nerve stimulation designed to provide non-addictive and non-invasive pain relief.
公司代碼HNGE
公司Hinge Health Inc
CEOPerez (Daniel Antonio)
網址https://en-gb.hingehealth.com/

常見問題

Hinge Health Inc(HNGE)的當前股價是多少?

Hinge Health Inc(HNGE)的當前股價是 47.920。

Hinge Health Inc 的股票代碼是什麼?

Hinge Health Inc的股票代碼是HNGE。

Hinge Health Inc股票的52週最高點是多少?

Hinge Health Inc股票的52週最高點是62.180。

Hinge Health Inc股票的52週最低點是多少?

Hinge Health Inc股票的52週最低點是33.423。

Hinge Health Inc的市值是多少?

Hinge Health Inc的市值是3.77B。

Hinge Health Inc的淨利潤是多少?

Hinge Health Inc的淨利潤為-11.93M。

現在Hinge Health Inc(HNGE)的股票是買入、持有還是賣出?

根據分析師評級,Hinge Health Inc(HNGE)的總體評級為買入,目標價格為63.929。

Hinge Health Inc(HNGE)股票的每股收益(EPS TTM)是多少

Hinge Health Inc(HNGE)股票的每股收益(EPS TTM)是-9.532。
KeyAI